The group's activity is to develop a system that assists in detecting breast cancer in a non-invasive and objective procedure. The group's breast cancer diagnostic device, the biofield diagnostic system, employs single-use sensors of our own design and a measurement device to detect and analyze changes associated with the development of epithelial cancers, such as breast cancer. The group operates mainly in the United States.
